Package 67751-171-01

{"route": ["ORAL"], "spl_id": "f70e0eb0-95aa-645c-e053-6394a90aae83", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1298324"], "spl_set_id": ["4226f394-f85e-45b1-8d5f-7cffb7dd492f"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Navajo Manufacturing Company Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (67751-171-01)  / 2 TABLET, EXTENDED RELEASE in 1 POUCH", "package_ndc": "67751-171-01", "marketing_start_date": "20160923"}], "brand_name": "Mucinex DM", "product_id": "67751-171_f70e0eb0-95aa-645c-e053-6394a90aae83", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "67751-171", "generic_name": "DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN", "labeler_name": "Navajo Manufacturing Company Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucinex DM", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "30 mg/1"}, {"name": "GUAIFENESIN", "strength": "600 mg/1"}], "application_number": "NDA021620", "marketing_category": "NDA", "marketing_start_date": "20160923", "listing_expiration_date": "20261231"}